sell

(redirected from CD62l)
Also found in: Dictionary, Thesaurus, Medical, Legal.
Related to CD62l: CD69, CD44, CCR7

Sell

To relinquish ownership of some asset in exchange for some monetary compensation. Selling may take any of several forms. In a cash sale, the seller receives cash or a cash equivalent immediately in exchange for the asset. In a credit sale, the seller surrenders ownership immediately in exchange for future payment, often with interest. An example of a sale is a simple transaction involving widgets. If the seller is willing to accept $2 per widget and the buyer wishes to purchase 100 widgets, then the seller gives to the buyer 100 widgets and in their place receives $200. See also: Buy.

sell

To dispose of an asset. Compare buy.

sell

see SELLING.
References in periodicals archive ?
The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes.
Choi y colaboradores (2009) compararon el efecto de la privacion de arginina en cultivos celulares de linfocitos T y macrofagos murinos y observaron alteraciones muy significativas en la calidad y la magnitud de la respuesta de los linfocitos T y la expresion de los marcadores CD25, CD62L y CD28 (20).
Expression of CD62L showed a significant exposure-sex interaction (p = 0.
Cells were then labeled with the following fluorescence-conjugated monoclonal antibodies: anti-Rat CD45 PE, anti-Rat CD8a APC, anti-Rat CD44 PE, and anti-Rat CD62L (eBioscience, San Diego, CA, USA).
low] Marcadores fenotipicos CD16 +++ CD56 - / + Receptores inhibidores KIR +++ NKG2A - / + CD94 - / + ILT-2 + Moleculas de adhesion CD2 + CD62L - / + CD44 + LFA-1 ++ Receptores de citoquinas y quimioquinas Alta afinidad IL-2 - Baja afinidad IL-2 ++ IL-1 - / + CCR7 - CXCR1 +++ CXCR3 - / + CX3CR1 +++ Subgrupo de celulas NK [CD16.
Topical application of beryllium to C3H mice generated beryllium-specific sensitization that was documented by peripheral blood and LN beryllium lymphocyte proliferation tests (BeLPT) and by changes in LN T-cell activation markers, increased expression of CD44, and decreased CD62L.